Search Results 111-120 of 16573 for Megacolon

1. A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) Inhibitors - Mayo Clinic

   ... megacolon, or unremoved adenomatous colonic polyps; Prior or planned surgery for UC; Past or present ileostomy or colostomy; Any prior treatment with ...

2. Brain tumor - Doctors and departments - Mayo Clinic

   The Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center. This ...

3. Multiple endocrine neoplasia, type 1 (MEN 1) - Doctors and departments - Mayo Clinic

   Learn about diagnosis and treatment for multiple endocrine neoplasia, type 1 (MEN 1) — a rare disorder that causes tumors and overproduction of hormones.

4. A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors - Mayo Clinic

   ... megacolon, or unremoved adenomatous colonic polyps; Prior or planned surgery for UC; Past or present ileostomy or colostomy; Have received non-permitted ...

5. A Study to Evaluate the Safety, Effectiveness and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesalamine Treatment - Mayo Clinic

   Current or prior diagnosis of toxic megacolon or fulminant colitis. History of prior gastrointestinal tract stricture and/or prior surgical intervention in ...

6. An Extension of a Previous Study Evaluating the Use of SER-109 to Prevent Recurrent Clostridium Difficile Infections - Mayo Clinic

   Known or suspected toxic megacolon and/or known small bowel ileus; Active irritable bowel syndrome with diarrhea within the previous 12 months; Major GI ...

7. A Study to Learn More about How Individuals Process Specific Medications Based on Their Genes in Patients with Gastrointestinal Disorders - Mayo Clinic

   ... megacolon) which, in the opinion of the investigator, is likely irreversible. Patients who, in the opinion of the investigator, are likely to undergo ...

8. Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients - Mayo Clinic

   Known or suspected toxic megacolon and/or known small bowel ileus. Presence of colostomy or ileostomy. Concomitant antibiotic use within 48 hours of Visit 2 ...

9. Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection - Mayo Clinic

   Toxic megacolon;; Colonic perforation;; Concurrent laxatives or tube feeds, toxin binders, bile acid sequestrants, fecal microbiota transplant (FMT) (within 1 ...

10. A Study to Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection (CDI) - Mayo Clinic

    Life threatening or fulminant CDI with evidence of hypotension, septic shock, peritoneal signs or absence of bowel sounds, or toxic megacolon. Current ...